S&P 500   3,006.46 (+0.68%)
DOW   26,817.22 (+0.18%)
QQQ   193.37 (+0.88%)
AAPL   240.84 (+1.87%)
FB   189.10 (+1.75%)
MSFT   138.14 (+0.52%)
GOOGL   1,244.65 (+0.02%)
AMZN   1,781.32 (+1.35%)
CGC   20.44 (+1.14%)
MU   45.22 (+4.03%)
BABA   172.90 (+2.23%)
GE   8.84 (-1.34%)
AMD   32.19 (+3.94%)
T   38.26 (-0.55%)
F   9.05 (-2.58%)
ACB   3.70 (+0.54%)
PRI   125.65 (+1.72%)
NFLX   275.97 (+0.24%)
BAC   31.02 (+2.17%)
GILD   65.26 (+0.54%)
DIS   130.51 (-0.29%)
S&P 500   3,006.46 (+0.68%)
DOW   26,817.22 (+0.18%)
QQQ   193.37 (+0.88%)
AAPL   240.84 (+1.87%)
FB   189.10 (+1.75%)
MSFT   138.14 (+0.52%)
GOOGL   1,244.65 (+0.02%)
AMZN   1,781.32 (+1.35%)
CGC   20.44 (+1.14%)
MU   45.22 (+4.03%)
BABA   172.90 (+2.23%)
GE   8.84 (-1.34%)
AMD   32.19 (+3.94%)
T   38.26 (-0.55%)
F   9.05 (-2.58%)
ACB   3.70 (+0.54%)
PRI   125.65 (+1.72%)
NFLX   275.97 (+0.24%)
BAC   31.02 (+2.17%)
GILD   65.26 (+0.54%)
DIS   130.51 (-0.29%)
Log in

RESMED/IDR UNRESTR Stock Price, News & Analysis (ASX:RMD)

A$19.16
-0.10 (-0.52 %)
(As of 10/21/2019 02:13 PM ET)
Today's Range
A$19.13
Now: A$19.16
A$19.24
50-Day Range
A$19.05
MA: A$19.63
A$20.59
52-Week Range
A$12.65
Now: A$19.16
A$20.75
Volume977,570 shs
Average Volume1.82 million shs
Market Capitalization$27.47 billion
P/E Ratio68.43
Dividend Yield1.18%
BetaN/A
ResMed Inc develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. Read More…

Industry, Sector and Symbol

Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-858-7462400

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.61 billion
Cash FlowA$0.10 per share
Book ValueA$1.44 per share

Profitability

Miscellaneous

Employees5,940
Outstanding Shares1,433,929,984
Market Cap$27.47 billion
Next Earnings DateN/A
OptionableOptionable

Receive RMD News and Ratings via Email

Sign-up to receive the latest news and ratings for RMD and its competitors with MarketBeat's FREE daily newsletter.


RESMED/IDR UNRESTR (ASX:RMD) Frequently Asked Questions

What is RESMED/IDR UNRESTR's stock symbol?

RESMED/IDR UNRESTR trades on the ASX under the ticker symbol "RMD."

How often does RESMED/IDR UNRESTR pay dividends? What is the dividend yield for RESMED/IDR UNRESTR?

RESMED/IDR UNRESTR declared a Final dividend on Wednesday, July 31st. Stockholders of record on Thursday, September 19th will be given a dividend of 0.039 per share on Thursday, September 19th. This represents a dividend yield of 0.21%. The ex-dividend date is Wednesday, August 14th. View RESMED/IDR UNRESTR's Dividend History.

Has RESMED/IDR UNRESTR been receiving favorable news coverage?

Media coverage about RMD stock has trended somewhat positive recently, InfoTrie Sentiment reports. The research firm rates the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. RESMED/IDR UNRESTR earned a media sentiment score of 0.8 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for RESMED/IDR UNRESTR.

Who are some of RESMED/IDR UNRESTR's key competitors?

What other stocks do shareholders of RESMED/IDR UNRESTR own?

Who are RESMED/IDR UNRESTR's key executives?

RESMED/IDR UNRESTR's management team includes the folowing people:
  • Mr. Michael J. Farrell BE, SM, MBA, CEO & Director (Age 47)
  • Mr. Robert A. Douglas, Pres & COO (Age 59)
  • Mr. Brett A. Sandercock, Chief Financial Officer (Age 52)
  • Mr. David B. Pendarvis, Chief Admin. Officer, Global Gen. Counsel & Sec. (Age 60)
  • Mr. James Hollingshead, Pres of Sleep Bus. (Age 56)

What is RESMED/IDR UNRESTR's stock price today?

One share of RMD stock can currently be purchased for approximately A$19.16.

How big of a company is RESMED/IDR UNRESTR?

RESMED/IDR UNRESTR has a market capitalization of $27.47 billion and generates $2.61 billion in revenue each year. RESMED/IDR UNRESTR employs 5,940 workers across the globe.View Additional Information About RESMED/IDR UNRESTR.

What is RESMED/IDR UNRESTR's official website?

The official website for RESMED/IDR UNRESTR is http://www.resmed.com/.

How can I contact RESMED/IDR UNRESTR?

RESMED/IDR UNRESTR's mailing address is 9001 Spectrum Center Blvd, SAN DIEGO, CA 92123-1438, United States. The company can be reached via phone at +1-858-7462400.


MarketBeat Community Rating for RESMED/IDR UNRESTR (ASX RMD)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  77 (Vote Outperform)
Underperform Votes:  80 (Vote Underperform)
Total Votes:  157
MarketBeat's community ratings are surveys of what our community members think about RESMED/IDR UNRESTR and other stocks. Vote "Outperform" if you believe RMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel